Cargando…

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

Research within a gynecologic oncology population has lagged behind the uptake in use of medical cannabis for symptom control. This study seeks to evaluate patient experience with prescribed medical cannabis obtained through licensed dispensaries in women with gynecologic malignancies. A 43-item sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webster, Emily M., Yadav, Ghanshyam S., Gysler, Stefan, McNamara, Blair, Black, Jonathan, Tymon-Rosario, Joan, Zeybek, Burak, Han, Chanhee, Arkfeld, Christopher K., Andikyan, Vaagn, Menderes, Gulden, Huang, Gloria, Azodi, Masoud, Silasi, Dan-Arin, Santin, Alessandro D., Schwartz, Peter E., Ratner, Elena S., Altwerger, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Survey Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653050/ https://www.ncbi.nlm.nih.gov/pubmed/33204797 http://dx.doi.org/10.1016/j.gore.2020.100667

Ejemplares similares

Financial toxicity in patients with gynecologic malignancies: a cross sectional study
por: Zeybek, Burak, et al.
Publicado: (2021)

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
por: Roque, Dana M., et al.
Publicado: (2022)

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
por: Zeybek, Burak, et al.
Publicado: (2020)

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
por: Perrone, Emanuele, et al.
Publicado: (2020)

Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo
por: Perrone, Emanuele, et al.
Publicado: (2020)

Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer
por: Albright, Benjamin B., et al.
Publicado: (2018)

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas
por: Lopez, Salvatore, et al.
Publicado: (2020)

Robotic Versus Abdominal Hysterectomy for Very Large Uteri
por: Silasi, Dan-Arin, et al.
Publicado: (2013)

A Simple Approach to Specimen Retrieval via Posterior Colpotomy Incision
por: Clark, Lindsay E., et al.
Publicado: (2015)

A Novel Approach to Combined Vaginal and Laparoscopic Gynecological Surgery
por: Tierney, Christina, et al.
Publicado: (2019)

Pseudovascular Invasion: Minimally Invasive Surgery for Endometrial Cancer
por: Seifi, Farinaz, et al.
Publicado: (2019)

Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies
por: Blake, Erin A., et al.
Publicado: (2019)

An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva
por: Li, Jessie Y., et al.
Publicado: (2021)

Transvaginal Morcellation
por: Clark Donat, Lindsay, et al.
Publicado: (2015)

Robot-Assisted Abdominal Cerclage During Pregnancy
por: Zeybek, Burak, et al.
Publicado: (2016)

Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Port-Site Metastasis in Gynecological Malignancies
por: Benabou, Kelly, et al.
Publicado: (2021)

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro
por: Ferrari, Francesca, et al.
Publicado: (2015)

Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer
por: Webster, Emily M., et al.
Publicado: (2020)

Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study
por: Ricci, Stephanie, et al.
Publicado: (2017)

Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent
por: Webster, Emily M., et al.
Publicado: (2020)

Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
por: Li, Jessie Y., et al.
Publicado: (2021)

Gynecologic oncology fellowship leadership trends by gender
por: Rodriguez Yanes, Nicolle, et al.
Publicado: (2023)

Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature
por: Gressel, Gregory M., et al.
Publicado: (2015)

WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type
por: Andikyan, Vaagn, et al.
Publicado: (2009)

The association of sexual dysfunction with race in women with gynecologic malignancies
por: Frimer, M., et al.
Publicado: (2019)

Factors influencing residents’ interest in gynecologic oncology fellowship
por: Palisoul, Marguerite, et al.
Publicado: (2019)

Patient perspectives of telemedicine in gynecologic oncology during COVID
por: Nestlerode, Christina, et al.
Publicado: (2022)

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
por: Black, Jonathan D, et al.
Publicado: (2015)

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
por: Black, Jonathan D, et al.
Publicado: (2015)

Preparedness of Ob/Gyn residents for fellowship training in gynecologic oncology
por: Doo, David W., et al.
Publicado: (2015)

The gynecologic oncology fellowship interview process: Challenges and potential areas for improvement()
por: Gressel, Gregory M., et al.
Publicado: (2017)

Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists
por: Crafton, Sarah M, et al.
Publicado: (2016)

The perceptions of gynecologic oncology fellows on readiness for subspecialty training following OB/GYNRESIDENCY
por: Urban, Renata R., et al.
Publicado: (2019)

Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fair
por: Chambers, Laura M., et al.
Publicado: (2021)

Resilience, hope and flourishing are inversely associated with burnout among members of the Society for Gynecologic Oncology
por: Vetter, Monica Hagan, et al.
Publicado: (2018)

Robotic radical trachelectomy with an abdominally placed vaginal cerclage for containment of early stage cervical cancer()
por: Tymon-Rosario, Joan, et al.
Publicado: (2020)

Robotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus
por: Harold, Justin, et al.
Publicado: (2022)

Isolated torsion of the utero‐ovarian ligament
por: Hla, Audrey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5plqanieggieeuoekd5frmkjf2